TTR and amyloidosis: In the study center not involved in the recruitment of diabetic patients (Henri Mondor center), SFN was related to amyloidosis (61%), associated to familial transthyretin mutation or abnormal immunoglobulin light chain, primary Sjögren’s syndrome (8%), or a not fully characterized inflammatory or dysimmune cause (31%).